INOVIO PHARMACEUTICALS INC shareholders Q2 2023

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 135 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.

INOVIO PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
SUSQUEHANNA INTERNATIONAL GROUP, LLP 48,600$21,8700.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 757,413$338,1850.00%
HighTower Advisors, LLC 43,307$17,0000.00%
Daiwa Securities Group Inc. 720$00.00%
PATHSTONE FAMILY OFFICE, LLC 33,403$14,9140.00%
TIAA, FSB 14,383$6,4220.00%
Bogart Wealth, LLC 5$20.00%
Steward Partners Investment Advisory, LLC 57$250.00%
IFG Advisory, LLC 10,000$4,4650.00%
Larson Financial Group LLC 100$450.00%
Prime Capital Investment Advisors, LLC 44,335$19,7960.00%
GPS Wealth Strategies Group, LLC 50$220.00%
ExodusPoint Capital Management, LP 75,792$340.00%
Financial Gravity Asset Management, Inc. 0$170.00%
Apollon Wealth Management, LLC 10,000$4,4650.00%
CARY STREET PARTNERS INVESTMENT ADVISORY LLC 500$2230.00%
Aspire Private Capital, LLC 100$450.00%
Global Wealth Management Investment Advisory, Inc. 250$1120.00%
Avion Wealth 747$00.00%
Banque Cantonale Vaudoise 2,083$10.00%
External links

This page lists INOVIO PHARMACEUTICALS INC's shareholders in Q2 2023. To view INOVIO PHARMACEUTICALS INC's shareholder history, click here.